Skip to main content
. 2017 Oct 23;1(9):973–982. doi: 10.1002/hep4.1103

Figure 2.

Figure 2

Number of patients with HCV in the African cohort, by rs760519 genotype, who had none to mild, moderate, or advanced fibrosis/cirrhosis at the onset of treatment. Light gray represents none to mild fibrosis (Ishak fibrosis score 0‐2); dark gray represents moderate fibrosis (Ishak fibrosis score 3‐4); black represents advanced fibrosis or cirrhosis (Ishak fibrosis score 5‐6).